SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5gza'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 11	GLY A 86 VAL A 93 ALA A 104 TYR A 149 SER A 154 LEU A 214	ADP A 401 (-3.6A) ADP A 401 (-4.4A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 ( 4.2A) ADP A 401 (-4.4A)	0.47A	2evaA-5gzaA: 20.5	2evaA-5gzaA: 25.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 12	GLY A 86 VAL A 93 ALA A 104 TYR A 149 GLY A 153 ASP A 225	ADP A 401 (-3.6A) ADP A 401 (-4.4A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) MG A 402 ( 1.8A)	0.77A	2wgjA-5gzaA: 18.0	2wgjA-5gzaA: 26.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 5	ARG A 176 GLN A 178 LEU A 158 PHE A 288	None	1.29A	3ablC-5gzaA: 2.6 3ablJ-5gzaA: undetectable	3ablC-5gzaA: 21.02 3ablJ-5gzaA: 11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CE6_A_ADNA500_2 (ADENOSYLHOMOCYSTEINA SE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 5	GLN A 212 THR A 209 THR A 277 LEU A 246	MG A 403 (-2.6A) None None None	1.36A	3ce6A-5gzaA: undetectable	3ce6A-5gzaA: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	GLY A 86 GLY A 88 VAL A 93 ALA A 104 VAL A 133 TYR A 149 LEU A 214	ADP A 401 (-3.6A) ADP A 401 (-3.1A) ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 (-4.4A)	0.49A	3fupB-5gzaA: 22.2	3fupB-5gzaA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0E_A_B49A9000_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 11	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.76A	3g0eA-5gzaA: 17.7	3g0eA-5gzaA: 23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0F_B_B49B9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 10	VAL A 93 ALA A 104 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.65A	3g0fB-5gzaA: 18.2	3g0fB-5gzaA: 23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G5D_A_1N1A1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.48A	3g5dA-5gzaA: 20.0	3g5dA-5gzaA: 28.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N62_B_ACTB860_0 (NITRIC OXIDE SYNTHASE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	3 / 3	GLY A 137 TRP A 98 VAL A 79	None	0.75A	3n62B-5gzaA: undetectable	3n62B-5gzaA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N65_B_ACTB860_0 (NITRIC OXIDE SYNTHASE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	3 / 3	GLY A 137 TRP A 98 VAL A 79	None	0.71A	3n65B-5gzaA: undetectable	3n65B-5gzaA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N66_B_ACTB860_0 (NITRIC OXIDE SYNTHASE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	3 / 3	GLY A 137 TRP A 98 VAL A 79	None	0.73A	3n66B-5gzaA: undetectable	3n66B-5gzaA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.57A	3octA-5gzaA: 19.5	3octA-5gzaA: 25.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 12	ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.49A	3oezA-5gzaA: 12.7	3oezA-5gzaA: 28.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QLG_B_1N1B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.52A	3qlgB-5gzaA: 13.8	3qlgB-5gzaA: 28.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SXR_A_1N1A1_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.45A	3sxrA-5gzaA: 20.3	3sxrA-5gzaA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SXR_B_1N1B2_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.46A	3sxrB-5gzaA: 19.9	3sxrB-5gzaA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 10	GLY A 86 GLY A 88 VAL A 93 ALA A 104 TYR A 149 SER A 154 LEU A 214	ADP A 401 (-3.6A) ADP A 401 (-3.1A) ADP A 401 (-4.4A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 ( 4.2A) ADP A 401 (-4.4A)	0.73A	4ckjA-5gzaA: 22.1	4ckjA-5gzaA: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	8 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214 ASP A 225	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A) MG A 402 ( 1.8A)	0.80A	4mxoB-5gzaA: 14.0	4mxoB-5gzaA: 29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 ALA A 104 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 (-4.4A) ADP A 401 (-3.2A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.63A	4mxxB-5gzaA: 12.7	4mxxB-5gzaA: 29.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	7 / 12	VAL A 93 VAL A 133 THR A 147 TYR A 149 GLY A 153 LEU A 214 ASP A 225	ADP A 401 (-4.4A) None ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A) MG A 402 ( 1.8A)	0.91A	4otwA-5gzaA: 17.2	4otwA-5gzaA: 24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 12	ILE A 85 GLY A 86 VAL A 93 ALA A 104 TYR A 149 LEU A 214	ADP A 401 ( 4.9A) ADP A 401 (-3.6A) ADP A 401 (-4.4A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 (-4.4A)	0.54A	4qmzA-5gzaA: 12.6	4qmzA-5gzaA: 23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I9X_A_DB8A1001_1 (EPHRIN TYPE-A RECEPTOR 2)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 12	ILE A 85 ALA A 104 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 ( 4.9A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.57A	5i9xA-5gzaA: 19.4	5i9xA-5gzaA: 27.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I9Y_A_1N1A1001_1 (EPHRIN TYPE-A RECEPTOR 2)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 12	ILE A 85 ALA A 104 THR A 147 TYR A 149 GLY A 153 LEU A 214	ADP A 401 ( 4.9A) ADP A 401 (-3.2A) ADP A 401 ( 4.8A) ADP A 401 ( 4.8A) ADP A 401 ( 4.1A) ADP A 401 (-4.4A)	0.42A	5i9yA-5gzaA: 13.1	5i9yA-5gzaA: 27.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	6 / 12	GLY A 86 VAL A 93 ALA A 104 VAL A 133 THR A 157 LEU A 214	ADP A 401 (-3.6A) ADP A 401 (-4.4A) ADP A 401 (-3.2A) None None ADP A 401 (-4.4A)	0.52A	5l2iA-5gzaA: 15.7	5l2iA-5gzaA: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M5K_A_ADNA502_2 (ADENOSYLHOMOCYSTEINA SE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 4	GLN A 212 THR A 209 THR A 277 LEU A 246	MG A 403 (-2.6A) None None None	1.49A	5m5kA-5gzaA: undetectable	5m5kA-5gzaA: 19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M5K_C_ADNC502_2 (ADENOSYLHOMOCYSTEINA SE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 4	GLN A 212 THR A 209 THR A 277 LEU A 246	MG A 403 (-2.6A) None None None	1.50A	5m5kC-5gzaA: undetectable	5m5kC-5gzaA: 19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M66_B_ADNB502_2 (ADENOSYLHOMOCYSTEINA SE)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 4	GLN A 212 THR A 209 THR A 277 LEU A 246	MG A 403 (-2.6A) None None None	1.45A	5m66B-5gzaA: undetectable	5m66B-5gzaA: 19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZR_E_PFLE409_1 (PROTON-GATED ION CHANNEL)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 8	PRO A 283 TYR A 307 ILE A 306 VAL A 324	None	0.94A	5mzrE-5gzaA: undetectable	5mzrE-5gzaA: 15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VUO_B_ACTB804_0 (NITRIC OXIDE SYNTHASE, BRAIN)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	3 / 3	GLY A 137 TRP A 98 VAL A 79	None	0.74A	5vuoB-5gzaA: undetectable	5vuoB-5gzaA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	3 / 3	TYR A 183 LEU A 210 ASP A 159	None	0.75A	5zv2B-5gzaA: 18.6	5zv2B-5gzaA: 16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AYC_A_1YNA502_2 (PROTEIN CYP51)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 7	VAL A 155 LEU A 121 PHE A 186 LEU A 226	None	1.19A	6aycA-5gzaA: undetectable	6aycA-5gzaA: 13.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F3M_B_ADNB502_2 (-)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 4	GLN A 212 THR A 209 THR A 277 LEU A 246	MG A 403 (-2.6A) None None None	1.39A	6f3mB-5gzaA: undetectable	6f3mB-5gzaA: 19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5gza	PROTEIN O-MANNOSE KINASE (Danio rerio)	4 / 6	ARG A 176 GLN A 178 LEU A 158 PHE A 288	None	1.24A	6nmpC-5gzaA: undetectable 6nmpJ-5gzaA: undetectable	6nmpC-5gzaA: 21.02 6nmpJ-5gzaA: 11.70

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2EVA_A_ADNA498_1","TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"GLY A  86;VAL A  93;ALA A 104;TYR A 149;SER A 154;LEU A 214","ADP A 401 (-3.6A);ADP A 401 (-4.4A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 ( 4.2A);ADP A 401 (-4.4A)","0.47A","2evaA-5gzaA:20.5","2evaA-5gzaA:25.16"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"GLY A  86;VAL A  93;ALA A 104;TYR A 149;GLY A 153;ASP A 225","ADP A 401 (-3.6A);ADP A 401 (-4.4A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A); MG A 402 ( 1.8A)","0.77A","2wgjA-5gzaA:18.0","2wgjA-5gzaA:26.13"],["3ABL_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"ARG A 176;GLN A 178;LEU A 158;PHE A 288","None","1.29A","3ablC-5gzaA:2.6;3ablJ-5gzaA:undetectable","3ablC-5gzaA:21.02;3ablJ-5gzaA:11.70"],["3CE6_A_ADNA500_2","ADENOSYLHOMOCYSTEINASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"GLN A 212;THR A 209;THR A 277;LEU A 246"," MG A 403 (-2.6A);None;None;None","1.36A","3ce6A-5gzaA:undetectable","3ce6A-5gzaA:19.88"],["3FUP_B_MI1B1_1","TYROSINE-PROTEIN KINASE JAK2","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"GLY A  86;GLY A  88;VAL A  93;ALA A 104;VAL A 133;TYR A 149;LEU A 214","ADP A 401 (-3.6A);ADP A 401 (-3.1A);ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 (-4.4A)","0.49A","3fupB-5gzaA:22.2","3fupB-5gzaA:23.17"],["3G0E_A_B49A9000_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.76A","3g0eA-5gzaA:17.7","3g0eA-5gzaA:23.73"],["3G0F_B_B49B9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"VAL A  93;ALA A 104;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.65A","3g0fB-5gzaA:18.2","3g0fB-5gzaA:23.73"],["3G5D_A_1N1A1_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.48A","3g5dA-5gzaA:20.0","3g5dA-5gzaA:28.48"],["3N62_B_ACTB860_0","NITRIC OXIDE SYNTHASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",3,"GLY A 137;TRP A  98;VAL A  79","None","0.75A","3n62B-5gzaA:undetectable","3n62B-5gzaA:22.48"],["3N65_B_ACTB860_0","NITRIC OXIDE SYNTHASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",3,"GLY A 137;TRP A  98;VAL A  79","None","0.71A","3n65B-5gzaA:undetectable","3n65B-5gzaA:22.48"],["3N66_B_ACTB860_0","NITRIC OXIDE SYNTHASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",3,"GLY A 137;TRP A  98;VAL A  79","None","0.73A","3n66B-5gzaA:undetectable","3n66B-5gzaA:22.48"],["3OCT_A_1N1A663_1","TYROSINE-PROTEIN KINASE BTK","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.57A","3octA-5gzaA:19.5","3octA-5gzaA:25.81"],["3OEZ_A_STIA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.49A","3oezA-5gzaA:12.7","3oezA-5gzaA:28.48"],["3QLG_B_1N1B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.52A","3qlgB-5gzaA:13.8","3qlgB-5gzaA:28.48"],["3SXR_A_1N1A1_1","CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.45A","3sxrA-5gzaA:20.3","3sxrA-5gzaA:25.00"],["3SXR_B_1N1B2_1","CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.46A","3sxrB-5gzaA:19.9","3sxrB-5gzaA:25.00"],["4CKJ_A_ADNA2014_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"GLY A  86;GLY A  88;VAL A  93;ALA A 104;TYR A 149;SER A 154;LEU A 214","ADP A 401 (-3.6A);ADP A 401 (-3.1A);ADP A 401 (-4.4A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 ( 4.2A);ADP A 401 (-4.4A)","0.73A","4ckjA-5gzaA:22.1","4ckjA-5gzaA:23.19"],["4MXO_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",8,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214;ASP A 225","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A); MG A 402 ( 1.8A)","0.80A","4mxoB-5gzaA:14.0","4mxoB-5gzaA:29.13"],["4MXX_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;ALA A 104;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.63A","4mxxB-5gzaA:12.7","4mxxB-5gzaA:29.13"],["4OTW_A_DB8A1101_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",7,"VAL A  93;VAL A 133;THR A 147;TYR A 149;GLY A 153;LEU A 214;ASP A 225","ADP A 401 (-4.4A);None;ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A); MG A 402 ( 1.8A)","0.91A","4otwA-5gzaA:17.2","4otwA-5gzaA:24.14"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"ILE A  85;GLY A  86;VAL A  93;ALA A 104;TYR A 149;LEU A 214","ADP A 401 ( 4.9A);ADP A 401 (-3.6A);ADP A 401 (-4.4A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 (-4.4A)","0.54A","4qmzA-5gzaA:12.6","4qmzA-5gzaA:23.98"],["5I9X_A_DB8A1001_1","EPHRIN TYPE-A RECEPTOR 2","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"ILE A  85;ALA A 104;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 ( 4.9A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.57A","5i9xA-5gzaA:19.4","5i9xA-5gzaA:27.22"],["5I9Y_A_1N1A1001_1","EPHRIN TYPE-A RECEPTOR 2","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"ILE A  85;ALA A 104;THR A 147;TYR A 149;GLY A 153;LEU A 214","ADP A 401 ( 4.9A);ADP A 401 (-3.2A);ADP A 401 ( 4.8A);ADP A 401 ( 4.8A);ADP A 401 ( 4.1A);ADP A 401 (-4.4A)","0.42A","5i9yA-5gzaA:13.1","5i9yA-5gzaA:27.22"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",6,"GLY A  86;VAL A  93;ALA A 104;VAL A 133;THR A 157;LEU A 214","ADP A 401 (-3.6A);ADP A 401 (-4.4A);ADP A 401 (-3.2A);None;None;ADP A 401 (-4.4A)","0.52A","5l2iA-5gzaA:15.7","5l2iA-5gzaA:23.24"],["5M5K_A_ADNA502_2","ADENOSYLHOMOCYSTEINASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"GLN A 212;THR A 209;THR A 277;LEU A 246"," MG A 403 (-2.6A);None;None;None","1.49A","5m5kA-5gzaA:undetectable","5m5kA-5gzaA:19.75"],["5M5K_C_ADNC502_2","ADENOSYLHOMOCYSTEINASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"GLN A 212;THR A 209;THR A 277;LEU A 246"," MG A 403 (-2.6A);None;None;None","1.50A","5m5kC-5gzaA:undetectable","5m5kC-5gzaA:19.75"],["5M66_B_ADNB502_2","ADENOSYLHOMOCYSTEINASE","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"GLN A 212;THR A 209;THR A 277;LEU A 246"," MG A 403 (-2.6A);None;None;None","1.45A","5m66B-5gzaA:undetectable","5m66B-5gzaA:19.75"],["5MZR_E_PFLE409_1","PROTON-GATED ION CHANNEL","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"PRO A 283;TYR A 307;ILE A 306;VAL A 324","None","0.94A","5mzrE-5gzaA:undetectable","5mzrE-5gzaA:15.36"],["5VUO_B_ACTB804_0","NITRIC OXIDE SYNTHASE, BRAIN","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",3,"GLY A 137;TRP A  98;VAL A  79","None","0.74A","5vuoB-5gzaA:undetectable","5vuoB-5gzaA:22.48"],["5ZV2_B_LEVB801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",3,"TYR A 183;LEU A 210;ASP A 159","None","0.75A","5zv2B-5gzaA:18.6","5zv2B-5gzaA:16.98"],["6AYC_A_1YNA502_2","PROTEIN CYP51","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"VAL A 155;LEU A 121;PHE A 186;LEU A 226","None","1.19A","6aycA-5gzaA:undetectable","6aycA-5gzaA:13.75"],["6F3M_B_ADNB502_2","-","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"GLN A 212;THR A 209;THR A 277;LEU A 246"," MG A 403 (-2.6A);None;None;None","1.39A","6f3mB-5gzaA:undetectable","6f3mB-5gzaA:19.35"],["6NMP_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5gza","PROTEIN O-MANNOSE KINASE","Danio rerio",4,"ARG A 176;GLN A 178;LEU A 158;PHE A 288","None","1.24A","6nmpC-5gzaA:undetectable;6nmpJ-5gzaA:undetectable","6nmpC-5gzaA:21.02;6nmpJ-5gzaA:11.70"]]